UBS AM’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-8,829
| Closed | -$210K | – | 2562 |
|
|
2022
Q3 | $210K | Sell |
8,829
-1,580
| -15% | -$37.6K | ﹤0.01% | 2594 |
|
|
2022
Q2 | $232K | Sell |
10,409
-8,829
| -46% | -$197K | ﹤0.01% | 2543 |
|
|
2022
Q1 | $483K | Hold |
19,238
| – | – | ﹤0.01% | 2476 |
|
|
2021
Q4 | $689K | Hold |
19,238
| – | – | ﹤0.01% | 2405 |
|
|
2021
Q3 | $819K | Buy |
19,238
+3,253
| +20% | +$138K | ﹤0.01% | 2269 |
|
|
2021
Q2 | $692K | Sell |
15,985
-558
| -3% | -$24.2K | ﹤0.01% | 2402 |
|
|
2021
Q1 | $675K | Hold |
16,543
| – | – | ﹤0.01% | 2273 |
|
|
2020
Q4 | $749K | Hold |
16,543
| – | – | ﹤0.01% | 2126 |
|
|
2020
Q3 | $585K | Buy |
16,543
+7,714
| +87% | +$273K | ﹤0.01% | 2067 |
|
|
2020
Q2 | $333K | Sell |
8,829
-6,955
| -44% | -$262K | ﹤0.01% | 2254 |
|
|
2020
Q1 | $456K | Sell |
15,784
-682
| -4% | -$19.7K | ﹤0.01% | 2008 |
|
|
2019
Q4 | $854K | Buy |
16,466
+633
| +4% | +$32.8K | ﹤0.01% | 1993 |
|
|
2019
Q3 | $869K | Buy |
15,833
+9,198
| +139% | +$505K | ﹤0.01% | 2022 |
|
|
2019
Q2 | $270K | Buy |
+6,635
| New | +$270K | ﹤0.01% | 2443 |
|
|
2018
Q2 | – | Sell |
-33
| Closed | -$1.64K | – | 2783 |
|
|
2018
Q1 | $1.64K | Hold |
33
| – | – | ﹤0.01% | 2636 |
|
|
2017
Q4 | $1.78K | Hold |
33
| – | – | ﹤0.01% | 2555 |
|
|
2017
Q3 | $1.91K | Hold |
33
| – | – | ﹤0.01% | 2506 |
|
|
2017
Q2 | $1.63K | Buy |
+33
| New | +$1.63K | ﹤0.01% | 2491 |
|
|
2016
Q4 | – | Sell |
-5,500
| Closed | -$263K | – | 2503 |
|
|
2016
Q3 | $263K | Hold |
5,500
| – | – | ﹤0.01% | 2333 |
|
|
2016
Q2 | $295K | Hold |
5,500
| – | – | ﹤0.01% | 2229 |
|
|
2016
Q1 | $246K | Hold |
5,500
| – | – | ﹤0.01% | 2317 |
|
|
2015
Q4 | $210K | Buy |
+5,500
| New | +$210K | ﹤0.01% | 2509 |
|
|
2015
Q2 | – | Sell |
-5,200
| Closed | -$214K | – | 2697 |
|
|
2015
Q1 | $214K | Buy |
+5,200
| New | +$214K | ﹤0.01% | 2455 |
|
|
2014
Q3 | – | Sell |
-4,800
| Closed | -$222K | – | 2562 |
|
|
2014
Q2 | $222K | Buy |
+4,800
| New | +$222K | ﹤0.01% | 2358 |
|